Viral envelopes are lipid membranes that surround certain viruses, stolen from the cells those viruses infect. Roughly half of all known virus families carry one, and it profoundly shapes how they spread, how the immune system recognizes them, and how easily they can be destroyed. The envelope is far more than passive packaging: it carries proteins that latch onto target cells, fuse membranes together, and dodge antibodies, while its lipid composition determines whether a splash of hand sanitizer can neutralize the virus in seconds.
Where the Envelope Comes From
An enveloped virus does not synthesize its own lipid membrane from scratch. Instead, during the final stage of replication, new virus particles wrap themselves in a patch of membrane borrowed from the host cell. This process, called budding, typically involves the virus co-opting the host’s own membrane-sculpting machinery. HIV, for example, hijacks a cellular system called ESCRT, the same protein complex that cells normally use to pinch off internal vesicles and to complete cell division.
1PubMed Central. Virus budding and the ESCRT pathwayNot every virus relies on ESCRT. Some encode their own proteins capable of bending and severing membranes, giving them independence from that particular host pathway.
2PubMed Central. Viral membrane scissionWhere the budding happens also varies. Influenza buds from the outer surface of the cell. HIV buds at the plasma membrane too, but certain herpesviruses acquire their envelope from internal compartments. The choice of budding site has practical consequences: it determines which host lipids and proteins end up in the final envelope, which in turn affects how the virus behaves once it leaves the cell.
A Lipid Bilayer That Is Not Simply a Copy of the Host
Because the envelope originates from the host’s own membranes, you might expect its lipid makeup to be a direct copy. It is not. Careful purification of influenza virions grown in eggs revealed that the dominant phospholipid in the virus membrane was phosphatidylethanolamine, whereas in typical mammalian cells the dominant one is phosphatidylcholine. Researchers quantified over 125 phospholipid species across three influenza strains and found consistent differences from the host, suggesting the virus does not grab membrane at random.
3PubMed Central. Lipid composition of viral envelope of three strains of influenza virus – not all viruses are created equalHIV tells a similar story from a different angle. The cholesterol-to-phospholipid ratio in HIV’s envelope is roughly two and a half times higher than in the host cell’s plasma membrane. That extra cholesterol makes the viral membrane more rigid and ordered, which likely helps the virus maintain structural integrity after it leaves the cell.
4PubMed. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranesThese findings matter because they point to selectivity: the virus preferentially buds through specific lipid-rich neighborhoods in the host membrane rather than through any arbitrary patch.
Lipid Rafts as Viral Staging Grounds
Those lipid-rich neighborhoods have a name: lipid rafts, also called membrane microdomains. These are small, cholesterol- and sphingolipid-enriched patches within the cell membrane that concentrate certain proteins and exclude others. Multiple virus families exploit rafts during both entry and exit. The general idea is that rafts act as organizing platforms: they cluster together the viral proteins needed for assembly, increasing the efficiency of the protein-protein interactions that drive budding.
5PubMed Central. Virus entry, assembly, budding, and membrane raftsDirect experimental evidence comes from studies using drugs that strip cholesterol from membranes. When vaccinia virus was exposed to cells treated with such a drug, the virus could still attach to the cell surface, but it could no longer penetrate and uncoat. Specific vaccinia envelope proteins were found in raft fractions of the cell membrane after infection at body temperature, but not when the virus merely sat on the cell surface in the cold without entering.
6PubMed Central. Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid raftsThis dependence on cholesterol-rich domains has practical implications: it is one reason cholesterol-depleting agents and detergents are so effective at disabling enveloped viruses.
Glycoproteins on the Surface
Studding the lipid bilayer are viral glycoproteins, the spikes visible in electron microscope images. These proteins handle the virus’s two most critical jobs: recognizing and binding to host cells, and fusing the viral membrane with a host membrane to deliver the genetic payload inside. The SARS-CoV-2 spike protein is perhaps the most publicly famous example. Structural studies showed it forms a trimer (a cluster of three identical subunits), with each subunit containing a receptor-binding domain that locks onto the ACE2 receptor on human cells. Uniquely among closely related coronaviruses, the SARS-CoV-2 spike contains a furin cleavage site at the boundary between its two major subunits, which is processed during the protein’s production inside the cell.
7PubMed Central. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinThe “glyco” in glycoprotein refers to sugars. These proteins are heavily decorated with sugar chains, called glycans, added by the host cell’s own machinery as the protein is made. The SARS-CoV-2 spike carries 22 sites for sugar attachment on each of its three subunits.
8PubMed Central. Site-specific glycan analysis of the SARS-CoV-2 spikeThose sugars are not decorative. Mutating individual glycan attachment sites on the spike often reduced the virus’s ability to infect cells, partly because the protein lost stability and was less efficiently incorporated into new virions. One particular sugar at position N343 in the receptor-binding domain had a direct role in helping the virus dodge antibodies from people who had recovered from infection, though vaccination could overcome that evasion.
9PubMed Central. SARS-CoV-2 spike glycosylation affects function and neutralization sensitivityThe Glycan Shield
Zoom out from individual sugar sites, and a striking picture emerges. Despite contributing only about 17 percent of the spike trimer’s total molecular weight, the glycans physically cover roughly 40 percent of the protein’s accessible surface. That sugar coating acts as a shield, blocking antibodies from reaching the protein underneath. The major exception is the receptor-binding domain itself, which must remain relatively exposed in order to grab onto host cells, creating a vulnerability the immune system can exploit.
10Trends in Biochemical Sciences. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognitionThis tradeoff between immune evasion and receptor access is a recurring theme across enveloped viruses. HIV takes glycan shielding to an extreme, with its envelope protein so densely sugar-coated that very few antibodies can find a gap. Influenza’s hemagglutinin is less shielded overall, but mutations that add or shift glycan sites accumulate over time, contributing to the virus’s ability to escape immunity from season to season.
How Enveloped Viruses Get Inside Cells
Entry follows a two-step logic. First, the virus binds to a receptor on the target cell’s surface. Then the viral and cell membranes fuse, creating an opening through which the genome slips inside. The fusion step can happen at the cell surface or after the virus has been swallowed into an internal compartment through endocytosis.
11PubMed Central. Entry of enveloped viruses into host cells: membrane fusionFor viruses that enter through endosomes, the trigger for fusion is usually the drop in pH inside those compartments. Some also require host enzymes in the endosome to clip the viral glycoprotein into its active form before fusion can proceed.
12PubMed Central. How endosomal PIKfyve inhibition prevents viral membrane fusion and entryHIV, by contrast, fuses directly at the cell surface after its envelope protein binds first to CD4, then to a co-receptor. These differences are not just academic: they determine which tissues a virus can infect and which drugs might block its entry.
Despite the variety of triggers, the fusion proteins themselves converge on a shared mechanism. Researchers have identified at least three structural classes of viral fusion proteins. Class I proteins, found on influenza, HIV, and coronaviruses, form trimeric bundles of alpha-helical coils. Class II proteins, found on flaviviruses, alphaviruses, and hantaviruses, are dominated by flat sheets of beta-strands arranged in three domains.
13PubMed Central. Mechanistic Insight into Bunyavirus-Induced Membrane Fusion from Structure-Function Analyses of the Hantavirus Envelope Glycoprotein GcClass III includes the fusion machinery of herpesviruses and rhabdoviruses. All three classes, however, end up doing the same thing: folding into a hairpin shape that yanks the viral membrane and the host membrane together until they merge.
14PubMed Central. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common themeMatrix Proteins and the Inner Scaffold
Between the lipid bilayer and the virus’s genetic core, many enveloped viruses have a layer of matrix proteins. These proteins act as a structural scaffold, linking the envelope to the internal components and playing a direct role in shaping the particle. In influenza, the M1 matrix protein can induce curvature in lipid membranes containing negatively charged lipids, even without any other viral components present. This bending requires M1 molecules to form stable connections with each other and assemble into a lattice; simply sticking to the membrane surface is not enough.
15PubMed Central. Influenza A matrix protein M1 is sufficient to induce lipid membrane deformationMatrix proteins also coordinate assembly. In influenza, recent cryo-electron tomography work showed that viral genome segments cluster together on membranes containing hemagglutinin in a process that depends on a host protein called Rab11a. Interestingly, when hemagglutinin was absent, the genome segments still clustered on membranes carrying neuraminidase, and virus assembly continued, demonstrating that membrane association is the key requirement, not a specific glycoprotein.
16PubMed Central. Visualizing influenza A virus assembly by in situ cryo-electron tomographyWhy Enveloped Viruses Are Easier to Destroy
The envelope is a virus’s greatest structural vulnerability. Because the lipid bilayer can be disrupted by soap, detergent, or alcohol, enveloped viruses are generally much easier to inactivate on surfaces and skin than their non-enveloped counterparts. Ethanol works by forming hydrogen bonds with the lipid bilayer, loosening the orderly packing of lipid chains and allowing alcohol to penetrate the membrane. In coronaviruses specifically, this disintegration of the lipid membrane triggers collapse of the spike protein and release of the virus’s internal contents.
17PubMed Central. Sensitivity Evaluation of Enveloped and Non-enveloped Viruses to Ethanol Using Machine Learning: A Systematic ReviewNon-enveloped viruses, lacking a lipid membrane, resist ethanol much more stubbornly. Alcohol can alter their capsid proteins, but the effect requires longer contact times and higher concentrations. This is why norovirus, a non-enveloped virus, is notoriously difficult to eliminate with standard alcohol-based hand sanitizers, while influenza and SARS-CoV-2 are quickly neutralized by them. The same vulnerability extends to environmental persistence: enveloped viruses tend to survive for shorter periods outside the body because their membranes dry out and degrade, while non-enveloped viruses like poliovirus can persist on surfaces for days or weeks.
Host Defenses That Target the Envelope
The immune system has evolved specific weapons against the viral envelope. Antibodies that bind to envelope glycoproteins can neutralize a virus by blocking receptor binding or by preventing the conformational changes needed for fusion. But cells also have a more direct trick: a protein called tetherin (also known as BST-2) that physically tethers newly budded virions to the cell surface, preventing them from drifting away to infect other cells. Tetherin is a membrane-anchored protein that works against a broad range of enveloped viruses, including HIV.
18PubMed Central. Structural insight into the mechanisms of enveloped virus tethering by tetherinHIV, in turn, encodes a protein called Vpu whose primary job is to counteract tetherin by targeting it for degradation. This molecular arms race between host restriction factors and viral countermeasures is a recurring pattern and illustrates how central the envelope is to viral fitness. A virus that cannot shed its tethered particles is effectively trapped.
Drugs and Vaccines That Exploit the Envelope
Because the envelope mediates the very first step of infection, it is a natural drug target. Entry inhibitors are compounds designed to block the fusion between viral and host membranes. The most prominent clinical example is enfuvirtide (brand name Fuzeon), a peptide that mimics part of HIV’s gp41 fusion protein. By binding to gp41 during the fusion process, enfuvirtide prevents the protein from completing the hairpin fold that merges the membranes, effectively locking the virus out of the cell.
19PubMed. Peptide-based inhibitors of the HIV envelope protein and other class I viral fusion proteinsThe broader class of entry inhibitors includes both peptides and small molecules, and research continues to expand the toolkit against multiple virus families.
20PubMed Central. Entry Inhibitors: Efficient Means to Block Viral InfectionOn the vaccine side, envelope glycoproteins are often the primary antigens. The discovery that certain antibodies can target the highly conserved stem region of influenza’s hemagglutinin, rather than its rapidly mutating head, has fueled efforts toward a universal flu vaccine. These stem-targeting antibodies neutralize a broad range of influenza strains and subtypes, and their structural characterization has guided the design of novel protein-based immunogens intended to elicit such broadly protective responses.
21PubMed Central. Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza HemagglutininGlycoprotein Dynamics in Real Time
Static crystal structures give a snapshot, but envelope glycoproteins are not still. Single-molecule fluorescence studies of the SARS-CoV-2 spike on intact virus particles revealed that the protein constantly shifts between at least four distinct conformational states.
22PubMed Central. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus ParticlesThese include configurations with the receptor-binding domain tucked down (hidden from antibodies) and popped up (ready to engage ACE2). Separate work on soluble spike constructs confirmed ongoing transitions between these up and down positions.
23eLife. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spikeThis breathing motion matters for both infection and immunity. A spike that spends most of its time in the “down” position is harder for antibodies to neutralize because the receptor-binding site is buried. But it also cannot infect cells efficiently in that state. Vaccines that lock the spike in a specific conformation, as the stabilized prefusion forms used in mRNA vaccines do, exploit this dynamic by presenting the immune system with a shape that exposes vulnerable sites the virus normally keeps hidden.
Cryo-electron tomography has become the tool of choice for watching these dynamics in three dimensions on intact virions and even catching intermediate stages of the fusion process as membranes merge.
24PubMed Central. Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plateQuasi-Enveloped Viruses and Blurred Categories
The neat division between enveloped and non-enveloped viruses has gotten messier. Hepatitis A and hepatitis E viruses were long classified as non-enveloped, but both are now known to leave infected liver cells cloaked in a host-derived membrane, making them “quasi-enveloped.” These membrane-wrapped forms circulate in the blood, shielded from antibodies, and only shed their borrowed coat when they reach the gut, where bile salts strip it away and expose the naked capsid for fresh rounds of infection.
25PubMed Central. Cell entry and release of quasi-enveloped human hepatitis virusesEven classically non-enveloped viruses get in on the act. Poliovirus, the textbook example of a naked virus, can exit cells inside extracellular vesicles carrying multiple virions at once along with viral RNA and replication proteins.
26Scientific Reports. Complexity and ultrastructure of infectious extracellular vesicles from cells infected by non-enveloped virusFor hepatitis E, the molecular details of quasi-envelope formation are coming into focus. A viral protein called ORF3 undergoes a chemical modification (palmitoylation) that allows it to associate with a host protein, Annexin II. Disrupting this interaction prevents the virus from efficiently secreting infectious particles.
27PubMed Central. Palmitoylation-dependent association with Annexin II directs hepatitis E virus ORF3 sorting into vesicles and quasi-enveloped virionsThese discoveries complicate diagnostics and treatment. A quasi-enveloped hepatitis A particle circulating in blood looks different to antibodies than the naked particle that a stool-based diagnostic test might detect. Understanding which form dominates at which stage of infection is an active area of research.
Pseudotyping and Biotechnology
Scientists have learned to swap viral envelopes the way you might swap cases on a phone. This technique, called pseudotyping, involves taking the core machinery of one virus (usually a disabled lentivirus derived from HIV) and dressing it in the envelope glycoproteins of a completely different virus. The result is a particle that enters cells the way the donor virus would, but carries a harmless genetic cargo instead of a dangerous genome.
Pseudotyped particles are used extensively in research to study dangerous viruses safely. Instead of working with live Ebola virus, for example, researchers can coat a harmless lentiviral backbone with Ebola’s envelope glycoprotein and study its entry behavior in a standard laboratory. Bat-derived filoviruses have been studied this way, revealing that their glycoproteins use the same host entry factors as Ebola and Marburg viruses, though with varying efficiency.
28PubMed Central. Comparison of the biological properties of bat-derived filovirus envelope glycoproteinsIn gene therapy, pseudotyping has direct clinical value. The most commonly used envelope protein for lentiviral gene therapy vectors is VSV-G, from vesicular stomatitis virus, because it gives the vector extremely broad cell tropism. But VSV-G is not ideal for all cell types. Swapping in glycoproteins from measles virus, baboon endogenous retrovirus, or other sources can improve transduction of specific target cells like blood stem cells, T cells, or natural killer cells.
29PubMed Central. Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene TherapyVectors pseudotyped with Aura virus glycoproteins, for instance, specifically target dendritic cells via the DC-SIGN receptor, making them potentially useful for immunotherapy applications where you want to deliver genes to the immune cells that orchestrate adaptive responses.
30PubMed Central. Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cellsExtracellular Vesicles and the Evolutionary Connection
The resemblance between enveloped viruses and the extracellular vesicles that normal, uninfected cells release is striking enough to raise evolutionary questions. Exosomes and other extracellular vesicles are similar in size to many viruses, bud through overlapping cellular pathways, and carry lipid bilayers studded with host proteins. When a virus-infected cell produces vesicles, those vesicles can incorporate viral proteins and fragments of viral RNA, making them virtually indistinguishable from defective, non-infectious retroviruses.
31PubMed Central. Extracellular vesicles and viruses: Are they close relatives?Whether enveloped viruses evolved from an ancestral vesicle-like communication system or whether the two lineages simply converged on the same membrane-wrapping solution is still debated. Either way, the overlap creates real problems for researchers trying to separate virus particles from vesicles in laboratory preparations, and it has implications for how we think about viral transmission, since vesicles carrying partial viral cargo could prime or modulate the immune response in ways that are only beginning to be understood.